Case Series

Outpatient ertapenem therapy in an ESBL-high-prevalence area: an efficacy, safety, and cost study

Ortiz-Álvarez A, Delgado-Ramírez MA, Cuevas-Zuñiga M, Hernández-Carrera T, Moncada Barrón D, Aguilar-Zapata D, Valdez Vázquez RR, Ramírez-Hinojosa JP, Rodríguez-Zulueta AP

Infection and Drug Resistance 2019, 12:111-117

Published Date: 28 December 2018